BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23168449)

  • 1. Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease.
    Rembach A; Doecke JD; Roberts BR; Watt AD; Faux NG; Volitakis I; Pertile KK; Rumble RL; Trounson BO; Fowler CJ; Wilson W; Ellis KA; Martins RN; Rowe CC; Villemagne VL; Ames D; Masters CL; AIBL research group ; Bush AI
    J Alzheimers Dis; 2013; 34(1):171-82. PubMed ID: 23168449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease.
    Squitti R; Ghidoni R; Siotto M; Ventriglia M; Benussi L; Paterlini A; Magri M; Binetti G; Cassetta E; Caprara D; Vernieri F; Rossini PM; Pasqualetti P
    Ann Neurol; 2014 Apr; 75(4):574-80. PubMed ID: 24623259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurements of serum non-ceruloplasmin copper by a direct fluorescent method specific to Cu(II).
    Squitti R; Siotto M; Cassetta E; El Idrissi IG; Colabufo NA
    Clin Chem Lab Med; 2017 Aug; 55(9):1360-1367. PubMed ID: 28076308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of serum non-ceruloplasmin copper in Alzheimer's disease.
    Squitti R; Simonelli I; Ventriglia M; Siotto M; Pasqualetti P; Rembach A; Doecke J; Bush AI
    J Alzheimers Dis; 2014; 38(4):809-22. PubMed ID: 24072069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with Increased Non-Ceruloplasmin Copper Appear a Distinct Sub-Group of Alzheimer's Disease: A Neuroimaging Study.
    Squitti R; Simonelli I; Cassetta E; Lupoi D; Rongioletti M; Ventriglia M; Siotto M
    Curr Alzheimer Res; 2017; 14(12):1318-1326. PubMed ID: 28669331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper subtype of Alzheimer's disease (AD): meta-analyses, genetic studies and predictive value of non-ceruloplasmim copper in mild cognitive impairment conversion to full AD.
    Squitti R
    J Trace Elem Med Biol; 2014 Oct; 28(4):482-5. PubMed ID: 25066791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.
    Siotto M; Simonelli I; Pasqualetti P; Mariani S; Caprara D; Bucossi S; Ventriglia M; Molinario R; Antenucci M; Rongioletti M; Rossini PM; Squitti R
    J Alzheimers Dis; 2016; 50(4):1181-9. PubMed ID: 26836154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An increased neutrophil-lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulation.
    Rembach A; Watt AD; Wilson WJ; Rainey-Smith S; Ellis KA; Rowe CC; Villemagne VL; Macaulay SL; Bush AI; Martins RN; Ames D; Masters CL; Doecke JD;
    J Neuroimmunol; 2014 Aug; 273(1-2):65-71. PubMed ID: 24907904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum copper and ceruloplasmin levels in Alzheimer's disease.
    Park JH; Lee DW; Park KS
    Asia Pac Psychiatry; 2014 Mar; 6(1):38-45. PubMed ID: 23857910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT).
    Sparks DL; Petanceska S; Sabbagh M; Connor D; Soares H; Adler C; Lopez J; Ziolkowski C; Lochhead J; Browne P
    Curr Alzheimer Res; 2005 Dec; 2(5):527-39. PubMed ID: 16375656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free copper and resting temporal EEG rhythms correlate across healthy, mild cognitive impairment, and Alzheimer's disease subjects.
    Babiloni C; Squitti R; Del Percio C; Cassetta E; Ventriglia MC; Ferreri F; Tombini M; Frisoni G; Binetti G; Gurzi M; Salinari S; Zappasodi F; Rossini PM
    Clin Neurophysiol; 2007 Jun; 118(6):1244-60. PubMed ID: 17462944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging.
    Gupta VB; Laws SM; Villemagne VL; Ames D; Bush AI; Ellis KA; Lui JK; Masters C; Rowe CC; Szoeke C; Taddei K; Martins RN;
    Neurology; 2011 Mar; 76(12):1091-8. PubMed ID: 21422459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excess of serum copper not related to ceruloplasmin in Alzheimer disease.
    Squitti R; Pasqualetti P; Dal Forno G; Moffa F; Cassetta E; Lupoi D; Vernieri F; Rossi L; Baldassini M; Rossini PM
    Neurology; 2005 Mar; 64(6):1040-6. PubMed ID: 15781823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer's Disease: A Case Control Study.
    Rozzini L; Lanfranchi F; Pilotto A; Catalani S; Gilberti ME; Paganelli M; Apostoli P; Padovani A
    J Alzheimers Dis; 2018; 61(3):907-912. PubMed ID: 29332043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer's Disease: a Genetic Study of ATP7B Frequency.
    Squitti R; Ventriglia M; Gennarelli M; Colabufo NA; El Idrissi IG; Bucossi S; Mariani S; Rongioletti M; Zanetti O; Congiu C; Rossini PM; Bonvicini C
    Mol Neurobiol; 2017 Jan; 54(1):671-681. PubMed ID: 26758278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal-score as a potential non-invasive diagnostic test for Alzheimer's disease.
    Squitti R; Pasqualetti P; Polimanti R; Salustri C; Moffa F; Cassetta E; Lupoi D; Ventriglia M; Cortesi M; Siotto M; Vernieri F; Rossini PM
    Curr Alzheimer Res; 2013 Feb; 10(2):191-8. PubMed ID: 23036026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Ceruloplasmin Copper Distinguishes A Distinct Subtype of Alzheimer's Disease: A Study of EEG-Derived Brain Activity.
    Tecchio F; Vecchio F; Ventriglia M; Porcaro C; Miraglia F; Siotto M; Rossini PM; Rongioletti M; Squitti R
    Curr Alzheimer Res; 2016; 13(12):1374-1384. PubMed ID: 27335037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free copper distinguishes mild cognitive impairment subjects from healthy elderly individuals.
    Squitti R; Ghidoni R; Scrascia F; Benussi L; Panetta V; Pasqualetti P; Moffa F; Bernardini S; Ventriglia M; Binetti G; Rossini PM
    J Alzheimers Dis; 2011; 23(2):239-48. PubMed ID: 20930297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper dyshomeostasis in Wilson disease and Alzheimer's disease as shown by serum and urine copper indicators.
    Squitti R; Ghidoni R; Simonelli I; Ivanova ID; Colabufo NA; Zuin M; Benussi L; Binetti G; Cassetta E; Rongioletti M; Siotto M
    J Trace Elem Med Biol; 2018 Jan; 45():181-188. PubMed ID: 29173477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients.
    Capo CR; Arciello M; Squitti R; Cassetta E; Rossini PM; Calabrese L; Rossi L
    Biometals; 2008 Jun; 21(3):367-72. PubMed ID: 18060472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.